EP 0555347 A4 19950111 - SUBSTITUTED INDOLIZINO 1,2-B)QUINOLINONES
Title (en)
SUBSTITUTED INDOLIZINO 1,2-B)QUINOLINONES
Publication
Application
Priority
- US 60621690 A 19901031
- US 78306391 A 19911025
Abstract (en)
[origin: WO9207856A1] The present invention provides a method of treating viral infections with substituted indolizino[1,2-b]quinolinone antiviral compounds, certain novel substituted indolizino[1,2-b]quinolinone compounds having antiviral activity, and pharmaceutical compositions thereof.
IPC 1-7
IPC 8 full level
A61K 31/47 (2006.01); A61P 31/12 (2006.01); C07D 471/14 (2006.01)
CPC (source: EP KR)
A61P 31/12 (2017.12 - EP); C07D 471/04 (2013.01 - KR); C07D 471/14 (2013.01 - EP)
Citation (search report)
- [A] CHEMICAL ABSTRACTS, vol. 85, no. 23, 1976, Columbus, Ohio, US; abstract no. 177759k, T. KAMETANI: "Mappicine" page 558; & JP H07691298 A
- [A] CHEMICAL ABSTRACTS, vol. 87, no. 3, 1977, Columbus, Ohio, US; abstract no. 23591d, T. KAMETANI: "Mappicine" page 684; & JP H07717499 A
- See references of WO 9207856A1
Designated contracting state (EPC)
AT BE CH DE DK ES FR GB GR IT LI LU NL SE
DOCDB simple family (publication)
WO 9207856 A1 19920514; AU 8940491 A 19920526; CA 2095219 A1 19920501; EP 0555347 A1 19930818; EP 0555347 A4 19950111; IE 913790 A1 19920522; JP H06502642 A 19940324; KR 930702289 A 19930908; NZ 240406 A 19940526; PT 99412 A 19921030
DOCDB simple family (application)
US 9108028 W 19911030; AU 8940491 A 19911030; CA 2095219 A 19911030; EP 91920258 A 19911030; IE 379091 A 19911030; JP 50087291 A 19911030; KR 930701318 A 19930501; NZ 24040691 A 19911030; PT 9941291 A 19911031